Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death-Reference-Cited by-同舟云学术

Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death

Published:2019-02 Issue:2 Volume:5 Page:152-161
ISSN:2405-500X
Container-title:JACC: Clinical Electrophysiology
language:en
Short-container-title:JACC: Clinical Electrophysiology

Author:

Masri Ahmad,Altibi Ahmed M.,Erqou Sebhat,Zmaili Mohammad A.,Saleh Ala,Al-Adham Raed,Ayoub Karam,Baghal Moaaz,Alkukhun Laith,Barakat Amr F.,Jain Sandeep,Saba Samir,Adelstein Evan

Funder

National Institutes of Health

Publisher

Elsevier BV

Reference38 articles.

1. U.S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Devices Evaluation, Division of Cardiovascular and Respiratory Devices, Pacemaker Defibrillator and Leads Branch. Summary of Safety and Effectiveness Data. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf/p010030b.Pdf. Accessed November 13, 2018.

2. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

3. Ventricular arrhythmia occurrence and compliance in patients treated with the wearable cardioverter defibrillator following percutaneous coronary intervention;Barraud;Heart Lung Circ,2018

4. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT);Barsheshet;J Cardiovasc Electrophysiol,2017

5. A real world wearable cardioverter defibrillator experience—very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center;Beiert;J Electrocardiol,2017

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of wearable cardioverter‐defibrillator use in Japan;Journal of Arrhythmia;2024-07-14

2. Critical appraisal of “Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189”. Comment to the authors reply;IJC Heart & Vasculature;2024-04

3. The Role of the Wearable Defibrillator in Heart Failure;Current Heart Failure Reports;2024-01-18

4. Correspondence: Authors’ reply to Critical appraisal of “Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189” by M. Nürnberg, F. Semrau;IJC Heart & Vasculature;2023-12

5. Critical appraisal of “Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189”;IJC Heart & Vasculature;2023-10